Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2500077	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-25		Sanofi Winthrop Industrie			view
JYSB2300135	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2023-08-15		Sanofi-Aventis Groupe;Sanofi Winthrop Industrie			view
JXSL2000177	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2020-10-14	Sanofi-aventis recherche & développement	Sanofi-Aventis Recherche & Developpement	In Review	2020-10-12	view
JXSS2500063	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2025-05-21		Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie			view
JYSB2400110	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17		Sanofi Winthrop Industrie			view
JYSB2200175	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-09-09		Sanofi-Aventis Groupe;Sanofi Winthrop Industrie			view
JYSB2500068	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-19		Sanofi Winthrop Industrie			view
JXSS2300007	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2023-01-12		Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie			view
JYSB2000388	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Supplementary Application	2020-08-21	Sanofi-aventis groupe	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	Filed	2020-09-02	view
JXSS2500056	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2025-05-13		Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie			view
JYSB2400077	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-04-04		Sanofi-Aventis Groupe;Sanofi Winthrop Industrie			view
JXSS2101006	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2021-05-10		Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie			view
JXSL2400123	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2024-07-12		Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie			view
JXSL2200187	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2022-10-27		Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd			view
JYSB2300134	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2023-08-15		Sanofi-Aventis Groupe;Sanofi Winthrop Industrie			view
JXSL2000176	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2020-10-14	Sanofi-aventis recherche & développement	Sanofi-Aventis Recherche & Developpement	In Review	2020-10-12	view
JXSS2500060	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2025-05-13		Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie			view
JYSB2400109	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17		Sanofi Winthrop Industrie			view
JYSB2200081	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-05-07		Sanofi-Aventis Groupe;Sanofi Winthrop Industrie			view
JXSS2500026	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2025-03-15		Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie			view